Peer-reviewed/ Observational study/ People
- Canadian study found 7.3% of pregnant women experienced health events requiring time off work or school or needing medical attention, such as headaches, fatigue and a general feeling of being unwell, within a week after dose two of a COVID-19 mRNA vaccine, compared to 11.3% of vaccinated non-pregnant women.
- Study also looked at unvaccinated pregnant women and found 3.2% reported health events (as defined above) within a given week, suggesting some of the symptoms experienced by the vaccinated pregnant women may not be due to the vaccine.
- There was no significant difference in the rates of more serious health events leading to medical consultation in any of the groups.
- Authors say these data provide reassuring evidence that COVID-19 mRNA vaccines are safe in pregnancy and call for pregnant people to be provided with accurate information about the possible adverse events after vaccination.
COVID-19 mRNA vaccines are safe to use in pregnancy and pregnant women experienced lower rates of health events post vaccination than similarly aged, non-pregnant vaccinated people, suggests a large Canadian study published in The Lancet Infectious Diseases journal.
The COVID-19 pandemic has disproportionately affected pregnant women, who are at higher risk of severe COVID-19 disease compared with similarly aged non-pregnant individuals. COVID-19 vaccines were recommended for use in pregnancy in many countries early on in vaccine deployment, based on established prior safety of inactivated vaccines in pregnancy and reassuring data from the small number of pregnancies occurring during pre-authorisation vaccine trials.
This study is one of the first to look at vaccine side effects in a group of vaccinated pregnant women at the same time as both an unvaccinated pregnant group and a vaccinated non-pregnant group to enable comparisons between the three.
“In the early stages of the COVID-19 vaccine rollout there was low vaccine uptake among pregnant people due to concerns about data availability and vaccine safety. There still is lower than average uptake among non-pregnant women of reproductive age,” says Dr Manish Sadarangani from the British Columbia Children’s Hospital Research Institute and first author on this study. [1] “Large, observational studies like ours are crucial for proper understanding of the rates of adverse health events in pregnant women after different doses of COVID-19 vaccination. This information should be used to inform pregnant women about the side effects they may experience in the week following vaccination.”
This new study, from The Canadian National Vaccine Safety (CANVAS) Network [2], looked at data from participants across seven Canadian provinces and territories between December 2020 and November 2021. All vaccinated participants were asked to self-report any health events during the seven days following each dose of COVID-19 vaccine. The unvaccinated pregnant control group was asked to record any health problems over the seven days before they filled out the survey. In total, 191,360 women aged 15-49 years with known pregnancy status completed the first dose survey and 94,937 completed the second dose survey.
A ‘significant health event’ was defined as a new or worse health event which was enough to cause the participant to miss school/work, require medical consultation and/or prevent daily activities in the previous seven days. ‘Serious health event’ was defined as any event resulting in an emergency department visit and/or hospitalisation in the previous seven days.
The researchers found that 4.0% (226/5,597) of mRNA-vaccinated pregnant females reported a significant health event within seven days after dose one of an mRNA vaccine, and 7.3% (227/3,108) after dose two. The most common significant health events after dose two in pregnant females were a general feeling of being unwell, headache/migraine, and respiratory tract infection.
In comparison, 3.2% (11/339) of pregnant unvaccinated participants reported similar events in the seven days prior to survey completion. In the vaccinated non-pregnant control group, 6.3% (10,950/174,765) reported a significant health event in the week after dose one and 11.3% (10,254/91,131) after dose two. Serious health events were rare in all groups (fewer than 1%) and occurred at similar rates in vaccinated pregnant individuals, vaccinated non-pregnant people and unvaccinated controls after dose one and dose two.
Miscarriage/stillbirth was the most frequently reported adverse pregnancy outcome with no significant difference between the rates in vaccinated and unvaccinated women; 2.1% (7/339) of unvaccinated pregnant women and 1.5% (83/5,597) of vaccinated pregnant women experienced a miscarriage or stillbirth within seven days after dose one of any mRNA vaccine.
“The lower rate of significant health events amongst vaccinated pregnant people, compared with vaccinated non-pregnant individuals, is unexpected and requires more research. Previous studies on other vaccines in pregnant women have mostly reported no significant differences in health events between pregnant and non-pregnant women or have found higher rates in pregnancy. Further studies of non-COVID-19 mRNA vaccines are required to identify if the reduced side effects observed in pregnant people in this study is a feature of the mRNA vaccine platform, or of these specific vaccines.” says Dr Julie Bettinger, senior author on this paper and also from the British Columbia Children’s Hospital Research Institute. [1]
The authors caution that most participants who reported ethnicity in this study were white and these data may therefore not be fully generalisable to other populations. Additionally, this study focused on health events occurring within the first seven days following vaccination and so cannot conclude anything about longer term reactions. However, longer-term follow-up of this cohort is ongoing. A further limitation of this study is that data are based on self-reports from study participants, without verification by medical records.
Writing in a linked comment, Dr Sascha Ellington and Dr Christine Olson from the Centers for Disease Control and Prevention in the USA (who were not involved in the study) note, “These findings are consistent with and add to the growing body of evidence that COVID-19 mRNA vaccines are safe during pregnancy. […] COVID-19 vaccination among pregnant people continues to be lower than among non-pregnant females of reproductive age. Given the risks of significant illness and adverse pregnancy outcomes, it is imperative that we continue to collect and disseminate data on the safety and effectiveness of COVID-19 vaccination in pregnancy and to encourage healthcare providers to promote vaccination during all trimesters of pregnancy.”
NOTES TO EDITORS
This study was funded by the Canadian Institutes of Health Research and the Public Health Agency of Canada through its COVID-19 Immunity Task Force. It was conducted by researchers from the Canadian Immunization Network’s (CIRN’s) CANVAS network, see the paper for the full list of authors.
The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf if you have any questions or feedback, please contact The Lancet press office [email protected]
[1] Quote direct from author and cannot be found in the text of the Article.
[2] https://cirnetwork.ca/network/national-ambulatory-network/
IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00426-1/fulltext
Journal
The Lancet Infectious Diseases
Method of Research
Observational study
Subject of Research
People
Article Title
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study
Article Publication Date
11-Aug-2022
COI Statement
MS has been an investigator on projects funded by GlaxoSmithKline,
Merck, Moderna, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo, and VBI
Vaccines. All funds have been paid to his institute, and he has not
received any personal payments. OGV has been an investigator,
coinvestigator, or expert panelist on projects funded by GlaxoSmithKline,
Merck, Pfizer, and Seqirus, outside of the submitted work. JDK has been
an investigator on projects funded by GlaxoSmithKline, Merck,
Moderna, and Pfizer. All funds have been paid to his institute, and he
has not received any personal payments. KAT has been an investigator
on projects funded by GlaxoSmithKline. All funds have been paid to her
institute, and she has not received any personal payments. JEI has been
an investigator on projects funded by GlaxoSmithKline, and SanofiPasteur. All funds have been paid to her institute, and she has not
received any personal payments. AJM has been an investigator on
projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, and
Seqirus, with funds paid to her institution, and has received honoraria
for participation in advisory boards from Astra-Zeneca,
GlaxoSmithKline, Medicago, Merck, Moderna, Pfizer, Sanofi-Pasteur,
Seqirus, and for presentations from Astra-Zeneca, and Moderna.
GDS has been an investigator on a project funded by Pfizer. All funds
have been paid to his institute, and he has not received any personal
payments. All other authors declare no competing interests.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
The Lancet Infectious Diseases: COVID-19 mRNA & Latest News Update
The Lancet Infectious Diseases: COVID-19 mRNA & More Live News
All this news that I have made and shared for you people, you will like it very much and in it we keep bringing topics for you people like every time so that you keep getting news information like trending topics and you It is our goal to be able to get
all kinds of news without going through us so that we can reach you the latest and best news for free so that you can move ahead further by getting the information of that news together with you. Later on, we will continue
to give information about more today world news update types of latest news through posts on our website so that you always keep moving forward in that news and whatever kind of information will be there, it will definitely be conveyed to you people.
The Lancet Infectious Diseases: COVID-19 mRNA & More News Today
All this news that I have brought up to you or will be the most different and best news that you people are not going to get anywhere, along with the information Trending News, Breaking News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, World News of this made available to all of you so that you are always connected with the news, stay ahead in the matter and keep getting today news all types of news for free till today so that you can get the news by getting it. Always take two steps forward
Credit Goes To News Website – This Original Content Owner News Website . This Is Not My Content So If You Want To Read Original Content You Can Follow Below Links